 Poor prognosis patients are defined as follows: ALL in 2nd CR belonging to the S3-S4 group; ALL in 3rd CR; AML in 2nd CR and relapsed less than 6 months after stop therapy; secondary AML; NHL in 3rd CR; Ph CML in 2nd CP, as well as in AP; RAEB, RAEB-t, JMML. 